Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40 - PubMed (original) (raw)
Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40
P Tomasec et al. Science. 2000.
Abstract
The nonclassical major histocompatibility complex (MHC) class I molecule HLA-E inhibits natural killer (NK) cell-mediated lysis by interacting with CD94/NKG2A receptors. Surface expression of HLA-E depends on binding of conserved peptides derived from MHC class I molecules. The same peptide is present in the leader sequence of the human cytomegalovirus (HCMV) glycoprotein UL40 (gpUL40). It is shown that, independently of the transporter associated with antigen processing, gpUL40 can up-regulate expression of HLA-E, which protects targets from NK cell lysis. While classical MHC class I molecules are down-regulated, HLA-E is up-regulated by HCMV. Induction of HLA-E surface expression by gpUL40 may represent an escape route for HCMV.
Similar articles
- HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ. Braud VM, et al. Nature. 1998 Feb 19;391(6669):795-9. doi: 10.1038/35869. Nature. 1998. PMID: 9486650 - Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis.
Ulbrecht M, Martinozzi S, Grzeschik M, Hengel H, Ellwart JW, Pla M, Weiss EH. Ulbrecht M, et al. J Immunol. 2000 May 15;164(10):5019-22. doi: 10.4049/jimmunol.164.10.5019. J Immunol. 2000. PMID: 10799855 - Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.
Heatley SL, Pietra G, Lin J, Widjaja JML, Harpur CM, Lester S, Rossjohn J, Szer J, Schwarer A, Bradstock K, Bardy PG, Mingari MC, Moretta L, Sullivan LC, Brooks AG. Heatley SL, et al. J Biol Chem. 2013 Mar 22;288(12):8679-8690. doi: 10.1074/jbc.M112.409672. Epub 2013 Jan 18. J Biol Chem. 2013. PMID: 23335510 Free PMC article. - Human leukocyte antigen E in human cytomegalovirus infection: friend or foe?
Gong F, Song S, Lv G, Pan Y, Zhang D, Jiang H. Gong F, et al. Acta Biochim Biophys Sin (Shanghai). 2012 Jul;44(7):551-4. doi: 10.1093/abbs/gms032. Epub 2012 May 9. Acta Biochim Biophys Sin (Shanghai). 2012. PMID: 22576308 Review. - Viral evasion of natural killer cells during human cytomegalovirus infection.
Braud VM, Tomasec P, Wilkinson GW. Braud VM, et al. Curr Top Microbiol Immunol. 2002;269:117-29. doi: 10.1007/978-3-642-59421-2_8. Curr Top Microbiol Immunol. 2002. PMID: 12224505 Review.
Cited by
- Deciphering the HLA-E immunopeptidome with mass spectrometry: an opportunity for universal mRNA vaccines and T-cell-directed immunotherapies.
Weitzen M, Shahbazy M, Kapoor S, Caron E. Weitzen M, et al. Front Immunol. 2024 Sep 5;15:1442783. doi: 10.3389/fimmu.2024.1442783. eCollection 2024. Front Immunol. 2024. PMID: 39301027 Free PMC article. Review. - Regulation of the cell surface expression of classical and non-classical MHC proteins by the human cytomegalovirus UL40 and rhesus cytomegalovirus Rh67 proteins.
Brackenridge S, John N, He W, Früh K, Borrow P, McMichael A. Brackenridge S, et al. J Virol. 2024 Sep 17;98(9):e0120624. doi: 10.1128/jvi.01206-24. Epub 2024 Aug 29. J Virol. 2024. PMID: 39207137 Free PMC article. - A monoclonal antibody that recognizes a unique 13-residue epitope in the cytoplasmic tail of HLA-E.
Verhaar ER, Gan J, Buhl S, Li Z, Horowitz A, Ploegh HL. Verhaar ER, et al. Mol Immunol. 2024 Aug;172:56-67. doi: 10.1016/j.molimm.2024.06.004. Epub 2024 Jun 19. Mol Immunol. 2024. PMID: 38901180 - CD8+ T cell targeting of tumor antigens presented by HLA-E.
Iyer RF, Verweij MC, Nair SS, Morrow D, Mansouri M, Chakravarty D, Beechwood T, Meyer C, Uebelhoer L, Lauron EJ, Selseth A, John N, Thin TH, Dzedzik S, Havenar-Daughton C, Axthelm MK, Douglas J, Korman A, Bhardwaj N, Tewari AK, Hansen S, Malouli D, Picker LJ, Früh K. Iyer RF, et al. Sci Adv. 2024 May 10;10(19):eadm7515. doi: 10.1126/sciadv.adm7515. Epub 2024 May 10. Sci Adv. 2024. PMID: 38728394 Free PMC article. - Engineering immune-evasive allogeneic cellular immunotherapies.
Martin KE, Hammer Q, Perica K, Sadelain M, Malmberg KJ. Martin KE, et al. Nat Rev Immunol. 2024 Sep;24(9):680-693. doi: 10.1038/s41577-024-01022-8. Epub 2024 Apr 24. Nat Rev Immunol. 2024. PMID: 38658708 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials